Ramius Advisors’s Pfizer PFE Stock Holding History

Ramius Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-421,600	Closed	-$611K	–	50
2020 Q1	$611K	Buy	+421,600	New	+$14.4M	0.15%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ramius Advisors's PFE Position: Q4 2020 in Review

Ramius Advisors sold out of Pfizer (PFE) in Q4 2020, closing a stake of 50,922 shares — an estimated $1.77M sold.

Ramius Advisors first reported a position in PFE in Q3 2019 and held it in 4 quarters. The position peaked at $3.65M in Q3 2019. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

Ramius Advisors reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
Ramius Advisors sold 50,922 Pfizer shares in Q4 2020, an estimated $1.77M.
Ramius Advisors first reported a position in Pfizer in Q3 2019 and held it in 4 quarters.
Ramius Advisors's Pfizer position peaked at $3.65M in Q3 2019.
2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Ramius Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.